Glycosaminoglycans in Thyroid-Associated Ophthalmopathy

References

• Heinegard D, Paulsson N., Piez KA, Reddi AH. Structure and metabolism of proteoglycans. Extracellular Matrix Biochemistry. Elsevier, New York 1984; 277–328
   Google Scholar
• Poulsen JH. Urine and tissue glycosaminoglycans and their interrelations. Dan Med Bull 1986; 33: 75–96
   PubMedGoogle Scholar
• Kaplan D, Meyer K. The fate of injected mucopolysaccharides. J Clin Invest 1962; 41: 743–749
   PubMed Web of Science ®Google Scholar
• Wood KM, Curtis CG, Powell GM, Wusteman FS. The metabolic fate of chondroitin 4 (35S) sulphate in the rat. Biochem Soc Trans 1973; 1: 840–842
   Google Scholar
• Elias JA, Krol RC, Freundlich B, Sampson PM. Regulation of human lung fibroblast glycosaminoglycan production by recombinant Interferon, Tumor Necrosis Factor, Lymphotoxin. J Clin Invest 1988; 81: 325–333
   PubMed Web of Science ®Google Scholar
• Iozzo RU. Proteoglycans: Structure, function and role in neoplasia. Lab Invest 1985; 53: 373–395
   PubMed Web of Science ®Google Scholar
• Ruoslahti E. Structure and Biology of proteoglycans. Ann Rev Cell Biol 1988; 4: 229–255
   PubMedGoogle Scholar
• Hiro D, Ito A., Matsuta K, Mori Y. Hyaluronic acid is an endogenous inducer of Interleukin-1 production by human monocytes and rabbit macrophages. Biochem Biophys Res Commun 1986; 140: 715–722
   PubMed Web of Science ®Google Scholar
• Smith TJ, Bahn RS, Gorman CA. Connective tissue, glycosaminoglycans, and diseases of the thyroid. Endocr Rev 1989; 10: 366–391
   PubMed Web of Science ®Google Scholar
• Singh SP, Nikiforuk K. Studies in relation to endocrine exophthalmos: the biochemical composition of human retrobulbar connective tissue. Experientia 1976; 32(2)395–396
   PubMedGoogle Scholar
• O'Brien JF. Glycosaminoglycans and exophthalmos. The Eye and the Orbit in Thyroid Disease, CA Gorman, RR Waller, JA Dyer. Raven Press, New York 1984; 43–47
   Google Scholar
• Toole N. Glycosaminoglycans in morphogenesis. Cell Biology of Extracellular Matrix, ED Hay. Plenum Press, New York 1981; 259–294
   Google Scholar
• Wegelius O, Asboe-Hansen G, Lamberg BA. Retrobulbar connective tissue changes in malignant exophthalmos. Acta Endocrinol 1957; 25: 452–456
   PubMedGoogle Scholar
• Campbell RJ. Immunology of Graves' ophthalmopathy: retrobulbar histology and histochemistry. Acta Endocrinol 1989; 121: 9–16
   Google Scholar
• Weetman AP, Cohen S, Gatter KC, Fells P, Shine B. Immunohistochemical analysis of the retobulbar tissues in Graves' ophthalmopathy. Clin Exp Immunol 1989; 75: 222–227
   PubMed Web of Science ®Google Scholar
• Hufnagel TJ, Hickey WF, Cobbs WH, Jakobiec FA, Iwamoto T, Eagle RC. Immunohistochemical and ultrastructural studies on the exenterated orbital tissues of a patient with Graves' disease. Ophthalmology 1984; 91: 1411–1419
   PubMed Web of Science ®Google Scholar
• Bahn RS, Gorman CA, Woloschak GE, Davis CS, Johnson PM, Johnson CM. Human retroocular fibroblasts in vitro: a model for the study of Graves' ophthalmopathy. J Clin Endocrinol Metab 1987; 65: 665–670
   PubMed Web of Science ®Google Scholar
• Hiromatsu Y, Fakazawa H, How J, Wall JR. Antibody-dependent cell-mediated cytotoxicity against human eye muscle cells and orbital fibroblasts in Graves' ophthalmopathy–roles of class II MHC antigen expression and gamma-interferon action on effector and target cells. Clin Exp Immunol 1987; 70: 593–603
   PubMed Web of Science ®Google Scholar
• Bahn RS, Gorman CA, Johnson CM, Smith TJ. Presence of antibodies in the sera of patients with Graves' disease recognizing a 23 kilodalton fibroblast protein. J Clin Endocrinol Melab 1989; 69: 622–628
   PubMed Web of Science ®Google Scholar
• Winand RJ, Wadeleux PA. Glycosaminoglycans and orbital connective tissue autoantibodies. Acta Endocrinol 1989; 121: 51–55
   Google Scholar
• Pennock CA. A review and selection of simple laboratory methods used for the study of glycosaminoglycan excretion and the diagnosis of mucopolysaccharidoses. J Clin Path 1976; 29: 111–123
   PubMed Web of Science ®Google Scholar
• Lowry O. Protein measurement with the Follin reagent. J Biol Chem 1951; 193: 3265–3275
   Google Scholar
• Beck B, Heintz B, Beyer J, Kahaly G. Humoral immunity and glycosaminoglycan synthesis in endocrine orbitopathy. Exp Clin Endocrinol 1991; 97: 360–361
   Google Scholar
• Fillit HM, Blake M, McDonald C, McCarthy M. Immunogenicity of liposome-bound hyaluronate in mice. J Exp Med 1988; 168: 971–982
   PubMedGoogle Scholar
• Wolf H, Nowak H, Wick G. Detection of antibodies interacting with glycosaminoglycan polysulfate in patients treated with heparine and other polysulfated glycosaminoglycans. Int Arch All Appl Immunol 1983; 70: 157–163
   PubMedGoogle Scholar
• Faaber P, Cappel PJA, Rijke GPM, Vierwinden G, van de Putte LBA, Koene RAP. Cross-reactivity of anti-DNA antibodies with proteoglycans. Clin Exp Immunol 1984; 55: 502–508
   PubMed Web of Science ®Google Scholar
• Schuler M, Liebschner K, Otto E, Beyer J, Kahaly G. Glycosaminoglycan antibodies in Graves' ophthalmopathy. Ann d'endocr 1991; 52: 63
   Google Scholar
• Munro RE, Lamki L, Row VV, Volpe R. Cell-mediated immunity in the exophthalmos of Graves' Disease as demonstrated by the migration inhibiting factor (MIF) test. J Clin Endocrinol Metab 1973; 37: 286–290
   PubMed Web of Science ®Google Scholar
• How J, Miller A, Laryea EA, Wall JR. Studies of cell-mediated immunity in Graves' ophthalmopathy using the antigen-induced leukocyte procoagulant activity assay. The Thyroid and Autoimmunity, HA Drexhage, WM Wiersinga. Elsevier BV, Amsterdam 1986; 270–271
   Google Scholar
• Postlewaite AE, Lachman LB, Kang AH. Stimulation of fibroblast hyaluronic acid production by human lnterleukin-1 (abstract). Arthritis Rheum 1983; 26: S59
   Google Scholar
• Schmidt JA, Mizel SB, Cohen D, Green I. Interleukin-1, a potential regulator of fibroblast proliferation. J Immunol 1982; 128(5)2177–2182
   PubMedGoogle Scholar
• Diegelmann RF, Cohen IK, Kaplan AM. Effect of macrophages on fibroblast DNA synthesis and proliferation. Proc Soc Exp Biol Med 1982; 169: 445–451
   PubMedGoogle Scholar
• Brandt R, Hedlof E, Asmann I, Bucht A, Tenglbad A. A convenient radiometric assay for hyaluronan. Acta Otolaryng 1987; 442: 31–35
   Google Scholar
• Winand RJ. Increased urinary excretion of acidic mucopolysaccharides in exophthalmos. J Clin Invest 1968; 47: 2563–2568
   PubMedGoogle Scholar
• Ursu H, Dumitrescu C, Bartoc R, Dumitriu L. Determination of urinary mucopolysaccharides in Graves' disease. Rev Roum Med 1984; 22: 277–282
   Google Scholar
• Glinoer D, Etienne-Decerf J, Schrooven M, Sand G, Hoyoux P, Mahieu P, Winand R. Beneficial effects of intensive plasma exchange followed by immunosuppressive therapy in severe Graves' ophthalmopathy. Acta Endocrinol 1986; 111: 30–38
   PubMedGoogle Scholar
• Kahaly G, Schuler M, Sewell AC, Bernhard G, Beyer J, Krause U. Urinary glycosaminoglycans in Graves' ophthalmopathy. Clin Endocrinol 1990; 33: 35–44
   PubMed Web of Science ®Google Scholar
• Kahaly G, Schuler M, Schmidt H, Stover C, Beyer J, Bernhard G. Plasma glycosaminoglycans in Graves' ophthalmopathy. Europ J Clin Invest
   Google Scholar
• Wall J, How J, Salvi M, Hiromatsu Y. Can endocrine exophthalmos be viewed as separate from thyroid autoimmunity. Bailliere's Clinical Immunology and Allergy, D Doniach, G Bottazzo. Bailliere Tindall, London 1987; 1: 141–163
   Google Scholar
• Wall JR, Salvi M, Bernard NF, Boucher A, Haegart D. Thyroid-associated ophthalmopathy–a model for the association of organ-spcific autoimmune disorders. Immunol Today 1991; 12: 150–153
   PubMedGoogle Scholar
• Jacobson DH, Gorman CA. Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis and treatment. Endocr Rev 1984; 5: 200–220
   PubMed Web of Science ®Google Scholar
• Marcocci C, Bartalena L, Bogazzi LG, Panicucci M, Pinchera A. Studies on the occurrence of ophthalmopathy in Graves' disease. Acta Endocrinol 1989; 120: 473–478
   PubMedGoogle Scholar
• Weetman AP. Thyroid-associated eye disease: pathophysiology. Lancet 1991; 338: 25–28
   PubMed Web of Science ®Google Scholar
• Salvi M, Bernard N, Miller A, Zhang ZG, Gardini E, Wall JR. Prevalence of antibodies reactive with a 64 kDa eye muscle membrane antigen in thyroid-associated ophthalmopathy. Thyroid 1991; 1(3)207–213
   PubMedGoogle Scholar
• Wall JR. Autoimmunity and Graves' ophthalmopathy. The Eye and Orbit in Thyroid Disease, CA Gorman, RR Waller, JA Dyer. Raven Press, New York 1984; 103–119
   Google Scholar
• Salvi M, Fukazawa H, Hiromatsu Y, Bernard N, How J, Wall JR. Role of auto-antibodies in the pathogenesis and association of endocrine autoimmune disorders. Endocr. Rev 1988; 9: 450–466
   PubMed Web of Science ®Google Scholar
• Salvi M, Zhang ZG, Haegert D, Woo M, Liberman A, Cadarso L, Wall JR. Patients with endocrine ophthalmopathy not associated with overt thyroid disease have multiple thyroid immunological abnormalities. J Clin Endocrinol Metab 1990; 70: 89–94
   PubMed Web of Science ®Google Scholar
• Carrino DA, Caplan AI. Isolation and partial characterization of high-buyant-density proteoglycans synthesized in ovo by embryonic chick skeletal muscle and heart. J Biol Chem 1984; 259: 12419–12430
   PubMedGoogle Scholar
• Koorneef L. The development of the connective tissue in the human orbit. Acta morphol neerl scand 1976; 14: 263–290
   PubMedGoogle Scholar
• Westermark K, Lilja K, Karlsson FA. Effects of sera and immunoglobulin preparations from patients with endocrine ophthalmopathy on the production of hyaluronate and the incorporation of tritiated thymidine in fibroblasts. Acta Endocrinol (Copenh) 1989; 121: 85–89
   Google Scholar
• Westergren-Thorsson G, Önnervik P-O, Fransson L-A, Malmstrom A. Proliferation of cultured fibroblasts in inhibited by L-iduronate-containing glycosaminoglycans. J Cell Physiol 1991; 147: 523–530
   PubMed Web of Science ®Google Scholar
• Hirsh J. Drug therapy: Heparin. New Engl J Med 1991; 324: 1565–1574
   PubMed Web of Science ®Google Scholar
• Anastassiades TP, Wood A. Effect of soluble products from lectin-stimulated lymphocytes on the growth, adhesiveness, and glycosaminoglycan synthesis of cultured synovial fibroblastic cells. J. Clin Invest 1981; 68: 792–801
   PubMedGoogle Scholar
• Wilson AP, Rider CC. Murine T lymphocytes and T-lymphoma cells produce chondroitin sulphate and heparan sulfate proteoglycans and free heparan sulfate glycosaminoglycan. Immunology 1991; 72: 27–33
   PubMedGoogle Scholar
• Sant AJ, Cullen SE, Schwartz BD. Biosynthetic relationships of the chondroitin sulphate proteoglycan with la and invariant chain glycoproteins. J Immunol 1985; 135: 416
   PubMedGoogle Scholar
• Jalkanen S, Jalkanen M, Bargatze R, Tammi M, Butcher EC. Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. J. Immunol 1988; 141: 1615
   PubMed Web of Science ®Google Scholar
• Bradbury MG, Parish CR. Characterization of lymphocyte receptors for glycosaminoglycans. Immunology 1991; 72: 231–238
   PubMed Web of Science ®Google Scholar
• Kimura K, Matsubara H, Sogoh S, Kita Y, Sakata T, Nishitani Y, Watanabe S, Hamaoka T, Fujiwara H. Role of glycosaminoglycan regulation of T-cell proliferation induced by thymic stroma-derived T cell growth factor. J Immunol 1991; 146(8)2618–2624
   PubMedGoogle Scholar
• Tanigushi N, Moriya N, Nanba I. Isolation and preliminary characterization of glycosaminoglycans in human plasma. Clin Chem Acta 1974; 50: 319–328
   Google Scholar